Level Bio AB (publ) (NGM:LEVBIO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2640
-0.0140 (-5.04%)
At close: Jul 24, 2026

Level Bio AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
33.5532.3625.126.134.3343.96
Revenue Growth
22.43%28.95%-3.83%-23.99%-21.91%86.86%
Gross Profit
17.9917.0613.4912.3115.2517.88
Operating Income
-2.71-3.49-8.08-9.73-2.335.26
Net Income
-2.87-3.54-7.87-9.48-2.225.16
Earnings Per Share
-0.04-0.05-0.12-0.15-0.040.08
EPS Growth
-----179.27%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.462.481.083.637.845.86
Total Debt
-21.411.110.60.9
Net Cash (Debt)
1.460.49-0.332.527.244.96
Net Cash Growth
8.63%---65.16%45.93%2154.38%
Net Cash Per Share
0.020.01-0.000.040.110.08

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.540.82-4.46-5.452.871.63
Capital Expenditures
----0.04-0.07-
Free Cash Flow
-0.540.82-4.46-5.492.791.63
Free Cash Flow Growth
----71.85%-11.61%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.63%52.70%53.77%47.16%44.43%40.67%
Operating Margin
-8.08%-10.78%-32.21%-37.30%-6.79%11.96%
Pretax Margin
-8.39%-11.02%-32.65%-37.15%-7.03%11.86%
Profit Margin
-8.56%-10.94%-31.37%-36.31%-6.48%11.73%
FCF Margin
-1.60%2.54%-17.78%-21.03%8.14%3.70%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----31.60
P/FCF Ratio
-25.01--16.92100.19
PS Ratio
0.540.630.750.991.383.71